$ATRA Income Statement | Understand Stock

$ATRA

$8.30 -$0.05 (0.6%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Commercialization revenue
License and collaboration revenue
Total revenue
Costs and operating expenses:
Cost of commercialization revenue
Research and development expenses
General and administrative expenses
Total operating expenses
Total costs and operating expenses

Loss from operations
Other income (expense), net:
Interest income
Interest expense
Gain on sale of ATOM Facility (See Note 7)
Other income (expense), net:
Total other income (expense), net
Loss before provision for (benefit from) income taxes
Provision for (benefit from) income taxes
Net loss
Other comprehensive gain (loss):
Unrealized gain (loss) on available-for-sale securities
Comprehensive loss
Net loss per common share:
Basic and diluted net loss per common share
Weighted-average shares outstanding used to calculate basic and diluted net loss per common share
Basis net loss per common share
Diluted net loss per common share
Basic weighted-average shares outstanding
Diluted weighted-average shares outstanding

Comments